News
GlaxoSmithKline Pharmaceuticals is a subsidiary of the GSK Group in India. Its objective is to get ahead of disease with the ...
reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE: GSK) for violations of §§10(b) ...
DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...
Hosted on MSN10mon
GSK shares drag the FTSE 100 as company faces muli-billion pound bill after Zantac trial rulingFor example, in Florida, a federal judge dismissed about 50,000 lawsuits against the company. Last month, in the first case to go before a jury, GSK and one of its peers won a case in Illinois.
As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory uncertainties, GSK and Pfizer have decided to lay to rest their patent | ...
GSK is betting on AI to boost innovation for its pipeline as investor concerns cloud over the company's research-and-development productivity, but a balanced approach toward regulation is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results